Blueprint Medicines Overview

Blueprint Medicines Selling, General & Admin

Selling, General & Admin expenses for BPMC.

Quarterly SG&A Expenses

$95.81M

↑ 14.66% YoY

As of Mar 31, 2025

Annual SG&A Expenses (TTM)

$371.52M

↑ 21.61% YoY

Trailing 12 months ending Mar 31, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin